Isozyme-Specific Pharmacological Properties of Protein Kinase C and Approaches to New Drug Development
蛋白激酶 C 同工酶特异性药理学特性和新药开发方法
基本信息
- 批准号:15390245
- 负责人:
- 金额:$ 6.02万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We tested hypothesis that JTV519 protects the cardiomyocytes from ischemia/reperfusion injury by inhibiting coupling of activated/translocated PKCd with its substrate proteins. We found that JTV519 facilitates translocation of PKCd while the phosphorylation of activation sites of PKCd is inhibited. Furthermore, JTV519 binds the translocated PKCd at a hydrophobic portion of annexin V. The data suggests that annexin V is a carrier protein of the unfoled/activated PKC in the cytosolic space and JTV519 may block the release of activated PKC from this carrier protein. The data provide the new approach to regulated the key enzyme activity such as PKCd in the subcellular space.
我们验证了JTV519通过抑制激活/转位的PKCd与其底物蛋白的偶联来保护心肌细胞免受缺血/再灌注损伤的假说。我们发现JTV519促进了PKCd的易位,而抑制了PKCd激活位点的磷酸化。此外,JTV519还将转位的PKCd结合到Annexin V的疏水部分。结果表明,Annexin V是胞液间隙中未折叠/激活的PKC的载体蛋白,JTV519可能阻止该载体蛋白释放激活的PKC。这些数据为调节亚细胞空间中的关键酶活性,如PKCd提供了新的途径。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yuan Z, Shioji K, Kihara Y, et al.: "Cardioproteicive effects of carvedilol on acute autoimmune myocarditis : anti-inflammatory effects associated with antioxidant properties"Am.J.Physiol.. 286. H83-H90 (2004)
Yuan Z、Shioji K、Kihara Y 等人:“卡维地洛对急性自身免疫性心肌炎的心脏保护作用:与抗氧化特性相关的抗炎作用”Am.J.Physiol.. 286. H83-H90 (2004)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Noguchi T, Kihara Y, et al.: "Altered myocardial thin-filament function in the failing Dahl salt-sensitive rat heart : amelioration by endothelin block"Circulation. 107. 630-635 (2003)
Noguchi T、Kihara Y 等人:“改变衰竭的 Dahl 盐敏感性大鼠心脏的心肌细丝功能:通过内皮素阻滞改善”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoneda T, Kihara Y, et al.: "RhoA expression is not a critical determinant in hypertension evolution in salt-sensitive Dahl rats"Med.Sci.Monit.. 9. BR399-BR402 (2003)
Yoneda T、Kihara Y 等人:“RhoA 表达不是盐敏感 Dahl 大鼠高血压演变的关键决定因素”Med.Sci.Monit.. 9. BR399-BR402 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Cardioprotective effects of carvedilol on acute autoimmune myocaridtis : anti-inflammatory effects associated with antioxidant property.
卡维地洛对急性自身免疫性心肌炎的心脏保护作用:与抗氧化特性相关的抗炎作用。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Yuan Z;Shioji K;Kihara Y;Takenaka H;Onozawa Y;Kishimoto C.
- 通讯作者:Kishimoto C.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIHARA Yasuki其他文献
KIHARA Yasuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIHARA Yasuki', 18)}}的其他基金
Metabolic Cardiomyopathy: Disease Entity and Pathophysiology
代谢性心肌病:疾病实体和病理生理学
- 批准号:
24591055 - 财政年份:2012
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of myocardial Tissue Tactors of ventricular remodeling
心室重构心肌组织因子的鉴定
- 批准号:
13670706 - 财政年份:2001
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Detection of mRNAscharacteristically expressed in heart failure transiti
心力衰竭转折过程中特征性表达的mRNA检测
- 批准号:
10670646 - 财政年份:1998
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cross Talk Between Protein Kinase C and Intracellular Calcium in the Cardiomyocyte
心肌细胞中蛋白激酶 C 和细胞内钙之间的串扰
- 批准号:
06454291 - 财政年份:1994
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Alterations in macrophage metabolism in heart failure with preserved ejection
射血保留性心力衰竭患者巨噬细胞代谢的改变
- 批准号:
502586 - 财政年份:2024
- 资助金额:
$ 6.02万 - 项目类别:
SBIR Phase II: In-vivo validation of a volume-manufacturable and factory-calibrated wearable NT-proBNP monitoring system for heart failure treatment
SBIR II 期:用于心力衰竭治疗的可批量生产和工厂校准的可穿戴 NT-proBNP 监测系统的体内验证
- 批准号:
2335105 - 财政年份:2024
- 资助金额:
$ 6.02万 - 项目类别:
Cooperative Agreement
RAPHAEL - Integrating a Palliative Care Approach for Patients with Heart Failure
RAPHAEL - 为心力衰竭患者整合姑息治疗方法
- 批准号:
10112701 - 财政年份:2024
- 资助金额:
$ 6.02万 - 项目类别:
EU-Funded
Exploratory research to elucidate the molecular mechanisms by which depression makes heart failure more severe and to reconstruct heart failure treatment strategies.
探索性研究旨在阐明抑郁症使心力衰竭更加严重的分子机制,并重建心力衰竭治疗策略。
- 批准号:
23K07507 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
- 批准号:
23K07526 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidating the Intricate Interplay between Mitochondria, Innate Immunity, and Viral Pathogenesis in Heart Failure
阐明心力衰竭中线粒体、先天免疫和病毒发病机制之间复杂的相互作用
- 批准号:
491149 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Fellowship Programs
Comparison of Machine Learning and Conventional Statistical Modeling for Predicting Readmission Following Acute Heart Failure Hospitalization
机器学习与传统统计模型预测急性心力衰竭住院后再入院的比较
- 批准号:
495410 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Elucidation of the precise mechanism of heart failure prevention by beta-catenin inhibition enabling the future development of a novel class of medicine
阐明β-连环蛋白抑制预防心力衰竭的精确机制,有助于未来开发一类新型药物
- 批准号:
23K15167 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel ventricular arrhythmias mechanism in ischemic heart failure focusing on neuropeptide Y
以神经肽Y为重点的缺血性心力衰竭室性心律失常新机制
- 批准号:
23K15119 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of novel pathophysiology and development of treatment for heart failure using human iPS cell-derived 3D heart tissue
利用人 iPS 细胞衍生的 3D 心脏组织阐明新的病理生理学并开发心力衰竭治疗方法
- 批准号:
23K15140 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists